Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Takeda Forecasts Tripling In Reported Op Profit Despite Virus Uncertainties
Lower Shire-Related Costs
May 13 2020
•
By
Ian Haydock
Takeda Sees Lower Costs, Entyvio Propelling Growth This Year • Source: Takeda
More from Business
More from Scrip